Ceredex Value Advisors LLC Sells 700 Shares of John Wiley & Sons, Inc. (NYSE:WLY)

Ceredex Value Advisors LLC cut its stake in shares of John Wiley & Sons, Inc. (NYSE:WLYFree Report) by 0.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 217,599 shares of the company’s stock after selling 700 shares during the period. Ceredex Value Advisors LLC owned 0.40% of John Wiley & Sons worth $10,499,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Mission Wealth Management LP increased its holdings in shares of John Wiley & Sons by 3.1% in the first quarter. Mission Wealth Management LP now owns 11,629 shares of the company’s stock worth $443,000 after purchasing an additional 350 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of John Wiley & Sons by 7.9% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,046 shares of the company’s stock valued at $778,000 after acquiring an additional 1,537 shares during the last quarter. Daiwa Securities Group Inc. grew its holdings in shares of John Wiley & Sons by 811.1% during the first quarter. Daiwa Securities Group Inc. now owns 8,200 shares of the company’s stock worth $313,000 after purchasing an additional 7,300 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of John Wiley & Sons in the first quarter worth approximately $252,000. Finally, Oppenheimer & Co. Inc. purchased a new stake in John Wiley & Sons in the first quarter valued at approximately $226,000. 73.94% of the stock is owned by hedge funds and other institutional investors.

John Wiley & Sons Trading Up 0.9 %

Shares of John Wiley & Sons stock opened at $49.72 on Friday. The company has a 50 day simple moving average of $47.99 and a two-hundred day simple moving average of $43.67. The firm has a market cap of $2.70 billion, a PE ratio of -24.86 and a beta of 0.85. John Wiley & Sons, Inc. has a 1 year low of $29.04 and a 1 year high of $51.79. The company has a debt-to-equity ratio of 1.27, a current ratio of 0.57 and a quick ratio of 0.53.

John Wiley & Sons (NYSE:WLYGet Free Report) last announced its earnings results on Thursday, September 5th. The company reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.08). John Wiley & Sons had a positive return on equity of 21.59% and a negative net margin of 6.00%. The company had revenue of $403.81 million during the quarter, compared to analysts’ expectations of $387.40 million. During the same quarter last year, the firm posted $0.27 earnings per share. The firm’s revenue was down 10.5% on a year-over-year basis.

John Wiley & Sons Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Investors of record on Tuesday, October 8th were given a $0.352 dividend. The ex-dividend date of this dividend was Tuesday, October 8th. This represents a $1.41 dividend on an annualized basis and a yield of 2.83%. John Wiley & Sons’s payout ratio is -70.50%.

Insiders Place Their Bets

In other news, EVP Danielle Mcmahan sold 2,318 shares of the business’s stock in a transaction that occurred on Tuesday, October 8th. The shares were sold at an average price of $49.41, for a total value of $114,532.38. Following the completion of the sale, the executive vice president now directly owns 8,978 shares in the company, valued at approximately $443,602.98. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.62% of the stock is owned by insiders.

John Wiley & Sons Company Profile

(Free Report)

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.

Featured Articles

Want to see what other hedge funds are holding WLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for John Wiley & Sons, Inc. (NYSE:WLYFree Report).

Institutional Ownership by Quarter for John Wiley & Sons (NYSE:WLY)

Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.